Showing all 15 results
Deflazacort Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Steroidal Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the glucocorticoid prodrug.
Active Ingredient Strength Primary Clinical Function Deflazacort USP/Ph.Eur. 6 mg The Pediatric & Titration Standard: The definitive unit utilized for weight-based dosing in pediatric Duchenne Muscular Dystrophy, slow tapering protocols, and chronic low-dose maintenance for rheumatoid arthritis. Deflazacort USP/Ph.Eur. 30 mg The Acute Flare-Up Macrodose: High-efficacy therapeutic payload utilized for the immediate, aggressive suppression of severe allergic anaphylaxis, acute asthma exacerbations, and violent autoimmune flare-ups. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Colloidal Silicon Dioxide Diluent / Binder / Superdisintegrant / Lubricant / Glidant (Engineered utilizing Extreme Multi-Stage Geometric Dilution to ensure the steroidal payload is flawlessly uniform, manufactured under strict OEB 4 containment protocols to prevent cross-contamination and protect facility operators) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict titration, tapering, and chronic immunological dispensing regimens).
Dienogest Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly potent steroidal API.
Active Ingredient Strength Primary Clinical Function Dienogest USP/Ph.Eur. 2 mg The Global Endometriosis Standard: The definitive therapeutic micro-dose utilized globally for the continuous, long-term suppression of pelvic pain, dysmenorrhea, and dyspareunia caused by endometriosis. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Crospovidone / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Lubricant / Heavy Film-Coating (Engineered specifically utilizing advanced multi-stage geometric dilution to ensure the 2mg steroidal payload is flawlessly uniform, finished with an opaque film-coat to seal the potent hormone safely away from factory handlers) *Pack Sizes: 14/28-Tablet Calendar Blisters (Optimized specifically for daily, uninterrupted, long-term gynecological dispensing).
DYDROGESTERONE TABLETS
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the retro-steroidal API.
Active Ingredient Strength Primary Clinical Function Dydrogesterone USP/Ph.Eur. 10 mg The Global Fertility & Maternal Standard: The definitive therapeutic unit utilized globally for luteal phase support, miscarriage prevention, and chronic endometriosis management. Excipients Lactose Monohydrate / Hypromellose / Maize Starch / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Disintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing high-shear wet granulation to ensure the 10mg steroidal payload is flawlessly uniform, finished with an opaque film-coat to lock the teratogen/hormone safely away from factory handlers) *Pack Sizes: 10×10 Blisters or Calendar Blisters of 14/28 (Optimized specifically for precise tracking during the menstrual cycle and IVF protocols).
Erlotinib Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the targeted antineoplastic API.
Active Ingredient Strength Primary Clinical Function Erlotinib (as Hydrochloride) USP/Ph.Eur. 100 mg The Pancreatic Oncology Standard: The definitive daily maintenance dose utilized globally in combination with Gemcitabine for advanced, unresectable, or metastatic pancreatic cancer. Erlotinib (as Hydrochloride) USP/Ph.Eur. 150 mg The Thoracic Oncology Standard: Massive therapeutic payload utilized as a first-line, maintenance, or second-line daily monotherapy for EGFR-mutated Non-Small Cell Lung Cancer. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to maximize dissolution of this highly insoluble compound while locking the potent cytotoxic API safely inside the tablet, completely preventing handler exposure to carcinogenic dust) *Pack Sizes: 3×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Ethinyestradiol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hazard-Shielded Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the synthetic steroidal API.
Active Ingredient Strength Primary Clinical Function Ethinylestradiol USP/Ph.Eur. 0.05 mg (50 mcg) The Endocrinology Standard: The definitive micro-dose engineered specifically for female hypogonadism, primary ovarian failure, and strictly monitored estrogen replacement. Ethinylestradiol USP/Ph.Eur. 1 mg The Palliative Oncology Macrodose: Massive therapeutic payload utilized strictly for the aggressive hormonal suppression of advanced, inoperable prostate or breast cancer. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Lubricant / Heavy Film-Coating (Engineered specifically to form an impenetrable physical barrier over the tablet core. This completely seals the potent steroidal API, ensuring absolute safety for handlers and guaranteeing zero cross-contamination in the facility) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict chronic endocrine and oncology dispensing regimens).
Ethinylestradiol & Levonorgestrel Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose FDC Tablet, packed exclusively in highly secure, moisture-resistant “Calendar Blister” packs to ensure absolute daily patient compliance and chemical stability.
Active Ingredient Strength Primary Clinical Function Ethinylestradiol USP/Ph.Eur. 0.03 mg (30 mcg) The Estrogenic Anchor: The synthetic estrogen required to suppress FSH release and stabilize the uterine lining to prevent irregular breakthrough bleeding. Levonorgestrel USP/Ph.Eur. 0.15 mg (150 mcg) The Progestin Powerhouse: The highly potent, second-generation progestin required to suppress the LH surge and thicken the cervical mucus. Excipients Lactose Monohydrate / Maize Starch / Povidone K-30 / Magnesium Stearate / Premium Sugar/Film Coating Diluent / Disintegrant / High-Shear Binder / Lubricant (Engineered specifically using elite multi-stage geometric dilution to guarantee the microscopic 30 mcg and 150 mcg payloads are flawlessly distributed, preventing lethal hormonal drops that cause contraceptive failure) *Pack Sizes: 21-Day Active Blisters OR 28-Day Calendar Blisters (21 Active Hormonal Tablets + 7 Placebo/Iron Tablets to enforce daily habit-forming compliance).
Everolimus Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Antioxidant-Stabilized Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the highly oxidative, potent API.
Active Ingredient Strength Primary Clinical Function Everolimus USP/Ph.Eur. 0.25 mg / 0.5 mg / 0.75 mg Global Transplant Standard: Ultra-micro doses utilized for strict, lifelong immunosuppression following renal or hepatic allografts. Requires extreme content uniformity to maintain the narrow therapeutic blood trough levels (3 to 8 ng/mL). Everolimus USP/Ph.Eur. 5 mg / 10 mg Global Oncology Standard: Massive-dose antineoplastic payload utilized for the aggressive suppression of Renal Cell Carcinoma, Neuroendocrine Tumors (NETs), and HR+/HER2- Breast Cancer. Excipients Butylated Hydroxytoluene (BHT) / Hypromellose / Lactose Anhydrous / Crospovidone / Magnesium Stearate Antioxidant / Binder / Diluent / Superdisintegrant / Lubricant (Engineered specifically utilizing BHT (Butylated Hydroxytoluene) to prevent the rapid oxidative degradation of the Everolimus molecule, guaranteeing maximum clinical shelf-life and potency across harsh climates) *Pack Sizes: 10×10 Alu-Alu Blisters (Transplant) or 3×10 Alu-Alu Blisters (Oncology – 30 Day Supply).
Exemestane Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the potent steroidal antineoplastic agent.
Active Ingredient Strength Primary Clinical Function Exemestane USP/Ph.Eur. 25 mg Global Adult Oncology Standard: The definitive daily maintenance dose required to maintain absolute, continuous destruction of peripheral aromatase enzymes and keep estrogen levels crashed. Excipients Mannitol / Copovidone / Crospovidone / Sodium Starch Glycolate / Magnesium Stearate / Premium Polymeric Film Diluent / High-Shear Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to lock the highly potent, teratogenic steroidal API safely inside the tablet, completely preventing handler and pharmacist exposure to the hazardous dust) *Pack Sizes: 10×10 Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Finasteride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hazard-Shielded Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly potent active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Finasteride USP/Ph.Eur. 1 mg The Global Dermatology Standard: The definitive micro-dose engineered specifically for the lifelong, daily maintenance of Androgenetic Alopecia (Male Pattern Hair Loss). Finasteride USP/Ph.Eur. 5 mg The Global Urology Standard: High-efficacy macro-dose utilized for the aggressive shrinkage of the prostate gland in symptomatic Benign Prostatic Hyperplasia (BPH). Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Docusate Sodium / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Opadry Film-Coating (Engineered specifically to form an impenetrable physical barrier over the tablet core. This completely seals the teratogenic API, ensuring absolute safety for female pharmacists and caregivers handling the medication) *Pack Sizes: 10×10 Blisters or Bottles of 30/100 (Optimized specifically for strict, lifelong chronic urology and dermatology dispensing regimens).
Gefitinib tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the targeted antineoplastic agent.
Active Ingredient Strength Primary Clinical Function Gefitinib USP/Ph.Eur. 250 mg Global Adult Oncology Standard: The definitive, highly precise daily maintenance dose required to maintain constant, paralyzing pressure on the mutated EGFR protein to keep the lung cancer in deep molecular remission. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to maximize the dissolution of this poorly soluble compound while locking the cytotoxic API safely inside the tablet, completely preventing handler and pharmacist exposure to the carcinogenic dust) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Imatinib tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the mesylate salt.
Active Ingredient Strength Primary Clinical Function Imatinib (as Mesylate) USP/Ph.Eur. 100 mg Pediatric & Titration Standard: Base therapeutic unit utilized for weight-based pediatric leukemia dosing, or for highly precise adult dose adjustments during acute hematological toxicity. Imatinib (as Mesylate) USP/Ph.Eur. 400 mg Global Adult Oncology Standard: High-efficacy adult maintenance dose, typically taken once daily for the chronic phase of CML, or twice daily for accelerated phases and GIST. Excipients Microcrystalline Cellulose / Crospovidone / Hypromellose / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Iron-Oxide Film Diluent / Superdisintegrant / Binder / Glidant / Heavy Film-Coating (Engineered specifically to lock the cytotoxic API safely inside the tablet, completely preventing handler and pharmacist exposure to the carcinogenic dust) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Melphalan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, handler-protective Amber Glass Bottles or specialized Alu-Alu cold-chain blisters to ensure the absolute chemical survival of the highly unstable alkylating agent.
Active Ingredient Strength Primary Clinical Function Melphalan USP/Ph.Eur. 2 mg Global Oncology Standard: Base therapeutic unit allowing for highly precise, weight-based or Body Surface Area (BSA) calculated “pulsed” dosing regimens. Excipients Microcrystalline Cellulose / Crospovidone / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Glidant / Slipper-Coating (Engineered specifically with a heavy film-coat to ensure immediate gastric transit and to completely seal the highly toxic, mutagenic core away from nurses and caregivers) *Pack Sizes: Amber Glass Bottles of 25/50 Tablets (Optimized specifically for strict, highly monitored hematology dispensing regimens).
